![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 9, 6133-6139, March 2, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
§,
,
,
,
, and

From the Type I interferons display a broad range of
immunomodulatory functions. Interferon
Service de Recherches en
Hémato-Immunologie, Comissariat à l' Energie Atomique,
DSV/DRM, Institut d'Hématologie, Hôpital
Saint-Louis, Centre Hayem 1, avenue Claude Vellefaux, 75475 Paris cedex
10, France, ¶ Laboratoire d'Immunologie Cellulaire et
Moléculaire, CNRS ESA 8078, Hôpital Marie-Lannelongue,
133, avenue de la Résistance, 92350 Le Plessis Robinson,
France,
Hôpital des Bluets, 9 rue des Bluets, 75011 Paris, France, and ** Fondation Jean Dausset, Centre d'Etude de
Polymorphisme Humain, 27, rue Juliette Dodu, 75010 Paris, France
increases gene expression at
the transcriptional level through binding of factors to the
interferon-stimulated response element (ISRE) within the promoters of
interferon-inducible genes, such as HLA class I. Despite mutation of
the class I ISRE sequence within the nonclassical HLA-G class I gene
promoter, we show that interferon
enhances both transcription and
cell surface expression of HLA-G in trophoblasts and amniotic and
thymic epithelial cells that selectively express it in
vivo. Deletion and mutagenesis analysis of a putative
interferon-regulatory factor (IRF)-1 binding site within the HLA-G
promoter show that HLA-G transactivation is mediated through an ISRE
sequence 746 base pairs upstream from ATG, which is distinct
from the interferon-responsive element described within proximal
classical class I gene promoters. Electrophoretic mobility shift
analysis and supershift analysis further demonstrate that
interferon-responsive transcription factors, including IRF-1,
specifically bind to the HLA-G ISRE. Our results provide evidence that
IRF-1 binding to a functional ISRE within the HLA-G promoter mediates
interferon
-induced expression of the HLA-G gene. These
observations are of general interest considering the implication of
HLA-G in mechanisms of immune escape involved in fetal-maternal
tolerance and other immune privilege situations.

To whom correspondence should be addressed. Tel.:
33-0-1-53-72-21-42; Fax: 33-0-1-48-03-19-60; E-mail:
paul@dsvidf.cea.fr.
This article has been cited by other articles:
![]() |
C. Ober, C. Billstrand, S. Kuldanek, and Z. Tan The miscarriage-associated HLA-G -725G allele influences transcription rates in JEG-3 cells Hum. Reprod., July 1, 2006; 21(7): 1743 - 1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lafon, C. Prehaud, F. Megret, M. Lafage, G. Mouillot, M. Roa, P. Moreau, N. Rouas-Freiss, and E. D. Carosella Modulation of HLA-G Expression in Human Neural Cells after Neurotropic Viral Infections J. Virol., December 15, 2005; 79(24): 15226 - 15237. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Tan, A. M. Shon, and C. Ober Evidence of balancing selection at the HLA-G promoter region Hum. Mol. Genet., December 1, 2005; 14(23): 3619 - 3628. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wiendl, U. Feger, M. Mittelbronn, C. Jack, B. Schreiner, C. Stadelmann, J. Antel, W. Brueck, R. Meyermann, A. Bar-Or, et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity Brain, November 1, 2005; 128(11): 2689 - 2704. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Moreau, G. Mouillot, P. Rousseau, C. Marcou, J. Dausset, and E. D. Carosella HLA-G gene repression is reversed by demethylation PNAS, February 4, 2003; 100(3): 1191 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Ibrahim, Y. Allory, F. Commo, B. Gattegno, P. Callard, and P. Paul Altered Pattern of Major Histocompatibility Complex Expression in Renal Carcinoma: Tumor-Specific Expression of the Nonclassical Human Leukocyte Antigen-G Molecule Is Restricted to Clear Cell Carcinoma While Up-Regulation of Other Major Histocompatibility Complex Antigens Is Primarily Distributed in All Subtypes of Renal Carcinoma Am. J. Pathol., February 1, 2003; 162(2): 501 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wiendl, M. Mitsdoerffer, V. Hofmeister, J. Wischhusen, E. H. Weiss, J. Dichgans, H. Lochmuller, R. Hohlfeld, A. Melms, and M. Weller The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy Brain, January 1, 2003; 126(1): 176 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. P. Gobin, P. Biesta, J. E. M. de Steenwinkel, G. Datema, and P. J. Van den Elsen HLA-G Transactivation by cAMP-response Element-binding Protein (CREB). AN ALTERNATIVE TRANSACTIVATION PATHWAY TO THE CONSERVED MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS I REGULATORY ROUTES J. Biol. Chem., October 11, 2002; 277(42): 39525 - 39531. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lila, N. Rouas-Freiss, J. Dausset, A. Carpentier, and E. D. Carosella Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism PNAS, September 19, 2001; (2001) 201407398. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Ibrahim, N. Guerra, M.-J. T. Lacombe, E. Angevin, S. Chouaib, E. D. Carosella, A. Caignard, and P. Paul Tumor-specific Up-Regulation of the Nonclassical Class I HLA-G Antigen Expression in Renal Carcinoma Cancer Res., September 1, 2001; 61(18): 6838 - 6845. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lila, N. Rouas-Freiss, J. Dausset, A. Carpentier, and E. D. Carosella Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism PNAS, October 9, 2001; 98(21): 12150 - 12155. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |